longevity researchBiological age testing methods: methylation vs blood vs functional
Biological age testing falls into three methodologies with very different costs, accuracy, and signals. Here's how each compares and which to start with.
There is no single canonical biological age test. There are three competing methodologies, each measuring a different biological substrate, each with its own cost structure, accuracy profile, and clinical utility. Choosing between them without understanding the trade-offs is how most men either overpay for a vanity number or under-invest in the data point that would have actually changed their behavior.
The three categories: DNA methylation clocks, blood-based composite scores, and functional performance tests. Below is what each one is actually measuring, how strong the underlying evidence is, and which to start with depending on what you are trying to find out.
Methylation: the gold standard, with caveats
DNA methylation clocks measure the pattern of methyl groups attached to cytosine bases at specific CpG sites across the genome. These patterns shift in tightly predictable ways with chronological aging, and the rate of shift correlates with mortality, disease incidence, and frailty better than any other consumer-accessible measurement.
The category began with the Horvath clock in 2013 (Horvath 2013), which used 353 CpG sites to estimate biological age across multiple tissue types. Subsequent clocks improved on the prediction. PhenoAge in 2018 incorporated phenotype-aging data and outperformed Horvath on mortality. GrimAge in 2019 trained directly on time-to-death and surpassed PhenoAge (Lu et al. 2019). DunedinPACE in 2022 introduced a rate-of-aging measure rather than a cumulative-age score.
The strongest validation data sits with GrimAge: each one-standard-deviation reduction corresponded to a 27% reduction in all-cause mortality in the Framingham cohort and similar effects in two replication cohorts (Lu et al. 2019).
Caveats matter. Methylation tests cost $250 to $500 per run. Test-retest variability on identical samples runs about 1.5 years, meaning small intra-individual changes are noise. The clocks are sensitive to acute confounders: recent illness, training the day before sampling, even sleep deprivation can shift methylation marks transiently. And methylation tells you the result without telling you which lever to pull.
Blood-based: the cost-to-signal winner
PhenoAge in its blood-based form requires nine variables from a standard comprehensive metabolic panel plus complete blood count plus hsCRP: albumin, creatinine, glucose, log-CRP, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase, and white blood cell count, plus chronological age (Levine et al. 2018).
The math weights each variable against its mortality association and produces a biological age estimate. The total input cost is roughly $60 to $120 from any direct-to-consumer lab. The signal correlates approximately 0.7 with methylation-based GrimAge across published cohorts.
The diagnostic advantage of blood-based testing is that the inputs are individually actionable. Methylation tells you that you are aging fast. PhenoAge tells you that your CRP is elevated and your glucose is creeping into the high 90s. The same number, but with a built-in intervention map.
The free Aging.AI calculator and similar tools take a standard panel and produce a PhenoAge number in seconds. Function Health, InsideTracker, and Levels.health build on the same underlying math with various UX layers.
For most men, the right entry point into biological age testing is not the $500 methylation kit. It is the $80 blood panel they already have annually, scored through a PhenoAge calculator.
Functional: the unsexy, free, validated option
The deepest mortality signal in middle-aged and older men is not in their methylation or their blood. It is in their VO2 max and their grip strength.
Mandsager and colleagues' 2018 JAMA Network Open analysis of 122,000 patients undergoing exercise treadmill testing found that the highest-fitness quintile had a 5-fold lower mortality risk than the lowest-fitness quintile (Mandsager et al. 2018). The effect was larger than smoking history, larger than diabetes, larger than coronary artery disease. VO2 max is not a marginal predictor. It is the predictor.
Grip strength is similar. The PURE study followed 140,000 adults across 17 countries and found each 5 kg reduction in grip strength was associated with a 16% increase in all-cause mortality, independent of age, education, and physical activity (Leong et al. 2015). Grip strength predicts mortality better than systolic blood pressure in many cohorts.
Both tests cost nothing to run. A reasonable VO2 max estimate comes from a 12-minute Cooper test or a graded treadmill test. Grip strength requires a $60 hand dynamometer. Functional metrics are not as photogenic as a $400 epigenetic report, but they are arguably the highest-signal data points in the entire biological age stack.
A reasonable benchmark for a 45-year-old man: VO2 max above 45 ml/kg/min puts you in the protective range. Grip strength above 50 kg per hand puts you in the upper half of your age group. Falling below either should prompt a serious training intervention before any methylation kit is opened.
The right biological age testing question is not which is most accurate. It is which one tells you something actionable that you don't already know.
How the three methods stack against each other
| Method | Cost | Mortality prediction | Actionability | Best use |
|---|---|---|---|---|
| Methylation (GrimAge, DunedinPACE) | $250–500 | Strongest | Low | Annual deep read |
| Blood-based (PhenoAge) | $60–150 | Strong | High | Quarterly tracking |
| Functional (VO2 max, grip) | $0–60 | Strong | Very high | Continuous |
The combinations matter. Methylation alone tells you where you stand. Blood-based alone tells you which biomarker is driving the result. Functional alone tells you what your trainable capacity is. The most useful baseline combines all three: methylation once, blood quarterly, functional continuously.
When biological age testing is worth the money
Three scenarios produce real ROI.
Baseline before intervention. If you are about to start a serious longevity protocol, a methylation test plus a PhenoAge plus a VO2 max measurement gives you a complete starting picture. The cost is the price of admission to running an experiment on yourself.
Mid-protocol calibration. Six to twelve months into a sleep, training, or metabolic intervention, a retest tells you whether the underlying biology actually moved. Subjective reports of feeling better are noise; biological age delta is signal. Compare against your own baseline, not against population norms.
Disease screening adjacent. PhenoAge running 5 to 10 years ahead of chronological age, with elevated CRP and high creatinine, is a soft signal to schedule a deeper workup. The test is not diagnostic, but it can flag a pattern that primary care often misses in otherwise asymptomatic men.
When the test is not worth running: as a one-time vanity metric, with no follow-up. As reassurance when you already know your sleep is bad and your training is sparse. As a substitute for the deeper labs (lipid subfractions, comprehensive thyroid, fasting insulin) that drive the actual interventions.
The protocol
- Start with what you already have. Pull a standard CMP, CBC, and hsCRP if you don't have one from the last 90 days. Run the numbers through a PhenoAge calculator (Aging.AI is free). Total cost: $80 to $120.
- Add functional data. Run a 12-minute Cooper test or a graded treadmill VO2 max estimate. Buy a hand dynamometer and measure both hands three times each. Total cost: $60 for the dynamometer.
- Decide if methylation is worth it. If your PhenoAge is within 3 years of chronological and your functional metrics are in the protective range, skip the methylation test. If PhenoAge is running hot, or you are entering a serious 12-month protocol, order GrimAge or DunedinPACE from TruDiagnostic or Elysium.
- Retest cadence. Blood-based quarterly. Methylation annually. Functional continuously through training data. Use the same lab and the same conditions every time.
- Always pair with a single-variable intervention. A test result with no downstream action is a number. A test result paired with one variable (sleep window, ApoB, training volume, alcohol) becomes a feedback loop.
For a deeper read on how to actually move biological age once you have a baseline, see how to reduce biological age, and start with the PrimalPrime biological age calculator for a quick first read on where you stand.
The methodology debate matters less than people think. The right test is the one that gives you a number you will act on. For most men, that is a $100 blood panel scored through PhenoAge, not a $500 methylation kit sitting in a drawer.